SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indrayani Biotech informs about board meeting

07 Jun 2023 Evaluate

Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indrayani Biotech has informed that, in accordance with Regulation 33(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, meeting of the Board of Directors will be held on Wednesday, 14th June, 2023 to consider and approve the following: The Audited Financial Results (Standalone and Consolidated) for the Quarter and year ended 31st March, 2023 along with the Audit report of Statutory Auditor and any other business with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Indrayani Biotech Share Price

12.14 0.13 (1.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2718.25
DCM Shriram 1225.85
3M India 31394.15
Hindustan Foods 509.15
Balmer Lawrie & Co 176.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×